Mascagni Wealth Management, Inc. Cytosorbents Corp Transaction History
Mascagni Wealth Management, Inc.
- $116 Billion
- Q4 2024
A detailed history of Mascagni Wealth Management, Inc. transactions in Cytosorbents Corp stock. As of the latest transaction made, Mascagni Wealth Management, Inc. holds 1,000 shares of CTSO stock, worth $1,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$1,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CTSO
# of Institutions
59Shares Held
15.7MCall Options Held
16KPut Options Held
0-
Avenir Corp Washington, DC3.09MShares$3.09 Million0.29% of portfolio
-
Skylands Capital, LLC2.78MShares$2.78 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.95 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.68 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.25MShares$1.25 Million0.18% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $43.6M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...